SIOGEN Biotech: Shermal Perera on the Deal with Veeda and Malaysian Biotech




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: SIOGEN Biotech: Shermal Perera on the Deal with Veeda and Malaysian Biotech
Released on: September 07, 2010. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this episode of PharmaTelevision News Review, Fintan Walton talks with Shermal Perera, Managing Director at SIOGEN Biotech.
  • Summary
  • Participants
  • Company
In this episode of PharmaTelevision News Review, Fintan Walton talks with Shermal Perera, Managing Director at SIOGEN Biotech. Filmed at BioChicago 2010 in Chicago, USA, they discuss:

• The origins of SIOGEN

• Basis of technology

• Business model

• SIOGEN's deal with Veeda

• The biotech industry in Malaysia

• The future of SIOGEN

Shermal Perera
Managing Director
SIOGEN Biotech
SIOGEN Biotech
SIOGEN Biotech is a Malaysia-based company, that focuses on developing silicon-based nanoparticle drug delivery.